Aerin Medical Inc, a company dedicated to providing ear, nose and throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, has closed a $60 million equity financing.
The financing was led by new investor Ally Bridge Group, with all existing major investors KCK MedTech, Questa Capital and OrbiMed also participating.
The company intends to use the proceeds to scale commercialisation and expand market access to meet the demand from physicians and their patients.
As part of the deal, Ally Bridge Group managing director Kevin Reilly has joined Aerin Medical’s Board of Directors.
